Redhill Biopharma
RDHL
$2.66
Share price
-3.62%
Change (1 day)
-80.65%
Change (1 year)
Categories
Earnings for Redhill Biopharma (RDHL)
Earnings in 2023 (TTM): $11.57 Million USD
According to Redhill Biopharma's latest financial reports the company's current earnings are $35.74 Million USD. In 2022 the company made an earning of -$71.67 Million USD, an increase over its 2021 earnings that were of -$97.75 Million USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Redhill Biopharma from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $11.57 M | -116.15% |
| 2022 | -$71.67 Million | -26.68% |
| 2021 | -$97.75 Million | 28.32% |
| 2020 | -$76.18 Million | 80.06% |
| 2019 | -$42.31 Million | 8.97% |
| 2018 | -$38.82 Million | -14.76% |
| 2017 | -$45.55 Million | 55.07% |
| 2016 | -$29.37 Million | 39.26% |
| 2015 | -$21.09 Million | 96.9% |
| 2014 | -$10.72 Million | 0.78% |
| 2013 | -$10.63 Million | 16.93% |
| 2012 | -$9.09 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | $7.94 B | 68,531.52% | 🇫🇷 France |
 | $21.20 B | 183,161.32% | 🇺🇸 USA |
 | $4.39 B | 37,875.63% | 🇬🇧 UK |
 | $43.72 M | 277.87% | 🇮🇱 Israel |
 | -$0.29 Billion | -2,536.92% | 🇮🇱 Israel |